External quality assessment scheme for HbA1c assays in Thailand : A 5-year experience
© 2022 The Authors..
Background: Thailand National External Quality Assessment Scheme (NEQAS) for HbA1c was established to evaluate the quality of HbA1c assays in Thailand in 2016.
Methods: HbA1c results from participating laboratories were compared to the target value assigned by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) reference system.
Results: The pass rates of participating laboratories during 2016-2020 were72-88%. The mean bias ranged between -0.19 and 0.20% of HbA1c. SD ranged from 0.30 to 1.08% of HbA1c. The overall coefficients of variation ranged from 4.46-15.66%.
Conclusions: Performance evaluation using IFCC assigned values indicated that different assay methods had an effect on HbA1c results. Participation in external quality assessment programs for HbA1c analysis is essential for improving laboratory quality and benefiting patient management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Practical laboratory medicine - 31(2022) vom: 05. Aug., Seite e00288 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Suparak, Supaporn [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Accuracy-based |
|---|
| Anmerkungen: |
Date Revised 16.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.plabm.2022.e00288 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34334789X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34334789X | ||
| 003 | DE-627 | ||
| 005 | 20231226020235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.plabm.2022.e00288 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1144.xml |
| 035 | |a (DE-627)NLM34334789X | ||
| 035 | |a (NLM)35814312 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Suparak, Supaporn |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a External quality assessment scheme for HbA1c assays in Thailand |b A 5-year experience |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Authors. | ||
| 520 | |a Background: Thailand National External Quality Assessment Scheme (NEQAS) for HbA1c was established to evaluate the quality of HbA1c assays in Thailand in 2016 | ||
| 520 | |a Methods: HbA1c results from participating laboratories were compared to the target value assigned by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) reference system | ||
| 520 | |a Results: The pass rates of participating laboratories during 2016-2020 were72-88%. The mean bias ranged between -0.19 and 0.20% of HbA1c. SD ranged from 0.30 to 1.08% of HbA1c. The overall coefficients of variation ranged from 4.46-15.66% | ||
| 520 | |a Conclusions: Performance evaluation using IFCC assigned values indicated that different assay methods had an effect on HbA1c results. Participation in external quality assessment programs for HbA1c analysis is essential for improving laboratory quality and benefiting patient management | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Accuracy-based | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a External quality assessment | |
| 650 | 4 | |a HbA1c | |
| 650 | 4 | |a Proficiency testing | |
| 700 | 1 | |a Pratumvinit, Busadee |e verfasserin |4 aut | |
| 700 | 1 | |a Ngueanchanthong, Kanokwan |e verfasserin |4 aut | |
| 700 | 1 | |a Unpol, Petai |e verfasserin |4 aut | |
| 700 | 1 | |a Thanomsakyuth, Ariya |e verfasserin |4 aut | |
| 700 | 1 | |a Setthaudom, Chavachol |e verfasserin |4 aut | |
| 700 | 1 | |a Kunakorn, Mongkol |e verfasserin |4 aut | |
| 700 | 1 | |a Rojanawiwat, Archawin |e verfasserin |4 aut | |
| 700 | 1 | |a Uppapong, Ballang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Practical laboratory medicine |d 2015 |g 31(2022) vom: 05. Aug., Seite e00288 |w (DE-627)NLM275285375 |x 2352-5517 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2022 |g day:05 |g month:08 |g pages:e00288 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.plabm.2022.e00288 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2022 |b 05 |c 08 |h e00288 | ||